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Abstract
Here we describe an in situ procedure with a labeling index (percent of labeled blood leukocytes)
>98%, which is high enough to permit the direct tracking of dendritic cell (DC) precursors from
blood into lymphoid tissues, while circumventing the pitfalls associated with in vitro labeling. DC
and lymphocytes have similar blood to afferent lymph migratory capabilities. This method has
additional applications in tracking other rare cell populations in both normal and pathological
states.
Introduction
Numerous investigators including our three laboratories have
studied leukocyte migration, particularly as it relates to
lymphocytes. This reassortment and recirculation of lympho-
cytes is fundamental for normal immune surveillance, dissem-
ination of the immune response, immunological memory, and
also plays a role in many pathologies and infectious diseases
(1). Previous investigations have characterized a variety of
unique cell traf®c migration streams. Among these are tissue-
speci®c and subset-speci®c cell traf®c patterns, such as the
differential homing of lymphocytes derived from blood, intes-
tinal lymph or s.c. lymph (2±5). Furthermore, the current
paradigm of the blood to lymph migratory differences between
naive and memory lymphocytes was established in sheep (6).
The dynamic kinetics of cell migration during normal and
pathological conditions has also been well characterized
(1,7,8).
All of these experiments have involved the isolation,
labeling and washing of cells in vitro with subsequent re-
injection into animals. Maintenance of physiologic integrity
has always been a concern, not only due to the time
(several hours) of in vitro preparation of cells, but also with
respect to the number of cells obtained for labeling.
Typically, in long-term experiments lasting several days or
weeks, optimizing these conditions has yielded labeling
indices in the blood and lymph that are of the order of 1%
(9,10). This labeling index has been suf®cient to study the
traf®c and recirculation patterns of major subsets of cells.
However, analysis of the kinetics and migration intricacies
of minor subsets of cells via staining with mAb in second
and third colors has been virtually impossible.
We have devised an in situ labeling approach which has
permitted a minor dendritic cell (DC) population to be directly
tracked from blood to lymphoid tissue. This in vivo adminis-
tration of carboxy¯uorescein diacetate succinimidyl ester
(CFSE) has achieved a blood leukocyte labeling index
>98%. The implications of this instantaneous labeling
technique extend beyond the tracking of DC to other
low-frequency cell populations in a variety of species.
Compartments with inherently low cell counts (e.g. afferent
lymph, peritoneal cavity) can now be more ef®ciently ana-
lyzed. This might be particularly relevant to extending studies
of the relationship of leukocytes in cerebral spinal ¯uid and the
lymphatic exit pathways from the central nervous system
(11±13).
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Methods
Animals
Outbred ewes 30±35 kg in weight were obtained from Renwick
farms (London, Ontario, Canada) or Versuchsbetrieb
Sennweid (Olsberg, Switzerland). Cannulae were surgically
established in prescapular efferent lymphatics or prescapular
pseudo-afferent lymphatics to allow chronic sampling of
lymph as previously described (14). In addition, a catheter
was also placed in the jugular vein to allow blood sampling. A
full day after surgery was allowed before cell labeling was
initiated to re-establish normal physiology. Handling of
animals and experimental procedures were conducted in
accordance with institutional and national guidelines for
animal care and use.
Immunophenotyping
Afferent lymph samples were collected at various intervals for
72 h after cell labeling. Staining for CD4, CD8, gdTCR, CD21,
CD1 and CD11c was performed using standard procedures in
conjunction with an appropriate allophycocyanin-conjugated
secondary antibodies (Southern Biotechnology Associates,
Birmingham, AL). Cells were ®xed in 1% paraformaldehyde
and analyzed on a FACSCalibur (Becton Dickinson, San Jose,
CA).
Cell labeling
Leukocyte labeling in Wistar rats was accomplished by
dissolving 0.8 mg of CFSE (Molecular Probes, Eugene, OR)
in 200 ml dimethyl sulfoxide (DMSO) with 10 ml heparin and
injecting this solution via the tail vein.
Leukocyte labeling in sheep was accomplished by dissolv-
ing 37 mg of CFSE in 6 ml of DMSO and 60 ml of heparin (1000
U/ml). This solution was injected into the blood via the jugular
vein in order to label blood leukocytes. Both blood and lymph
samples were collected in heparin, and kept on ice whenever
possible. Heparin is not needed to obtain cell labeling, but was
used as a precaution to avoid clotting. Other animals did not
receive heparin and equivalent labeling results were obtained.
Cell preparation for FACS
Blood samples were collected in heparin and kept on ice
whenever possible. Erythrocytes were lysed with distilled
water or ammonium chloride and cells were washed in PBS
Fig. 1. In vivo labeling of blood leukocytes. Blood samples were taken before labeling and 10 min after injection of CFSE i.v. in both sheep
and rats. (A and B) Histograms generated by ¯ow cytometric analysis, showing cell count versus CFSE intensity of unstained sheep blood
leukocytes and leukocytes 10 min post CFSE injection. (C and D) Results obtained using rat blood.
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twice. Cells were ®xed in 1% paraformaldehyde in PBS and
analyzed on a FACSCalibur ¯ow cytometer within a maximum
of 12 h.
Results
Blood leukocyte labeling
To investigate the ef®cacy of this labeling procedure we used
outbred ewes and female Wistar rats. Flow cytometric analysis
was employed to measure the ¯uorescence intensity of blood
leukocytes, before and after labeling for sheep (Fig. 1A and
1B) and rats (Fig. 1C and 1D) respectively. Blood samples
from both species taken 10 min after i.v. infusion of CFSE
demonstrated that >98% of all leukocytes in the sample
¯uoresced with a greater intensity than unstained leukocytes.
Recirculation of labeled lymphocytes
The functional capacity of cells loaded with CFSE was
investigated by observing the ability of lymphocytes to
recirculate from blood to lymph after in situ labeling. This is
a direct indication of cell function, as lymphocyte transen-
dothelial migration is an active process and dead or damaged
lymphocytes are not capable of recirculating (5). Chronic
efferent lymph collections from a cannulated prefemoral
efferent lymphatic in a conscious sheep were made to track
the migration of labeled lymphocytes from blood to lymph.
Histograms of cell count versus CFSE intensity are shown for a
lymph sample prior to blood labeling and for a sample
collected 18±20 h after blood labeling (Fig. 2A and B
respectively). This clearly demonstrates the functional status
of CFSE+ lymphocytes. In the example shown, 5.6% of efferent
lymph cells were CFSE+. Continuous sampling of efferent
lymph cells was also made over 40 h, by collecting all the
lymph exiting a single cannulated prefemoral efferent lymph-
atic (Fig. 2C). In this representative example shown the
highest percent of CFSE+ efferent lymph cells was recovered
in the collection made between 7 and 18 h. Propidium iodide
staining of cells from efferent lymph with 2% CFSE-labeled
cells was very similar: 1.8% of CFSE+ cells and 2.0% of non-
CFSE-labeled cells were propidium iodide-positive.
In vivo versus ex vivo labeling index
Direct comparison of ex vivo versus in vivo labeling techniques
was performed to assess the labeling index of lymphocytes.
The percent of labeled lymphocytes in the blood versus time
was investigated over a period of ~100 h. The reduction of
CFSE+ lymphocytes from the blood is shown for ex vivo
labeled cells where the lymphocytes contained in a unit of
blood (~400 ml) were incubated with CFSE in vitro and
returned to the venous circulation of a sheep (Fig. 3A). Also
shown is the reduction of lymphocytes after i.v. injection of
CFSE labeling the entire blood leukocyte pool (Fig. 3B). Both
curves show a similar reduction of lymphocytes from the blood
compartment. However, the labeling index of lymphocytes in
the blood is ~2000% higher with the in situ technique.
Figure 4(A and B) shows histograms of cell count versus
¯uorescence for spleen and mesenteric lymph node cells
respectively. Due to the fenestrated sinusoids in the spleen
creating a very open system of cellular exchange with the
blood, it is expected that CFSE+ cells would be present after 1 h.
However, migration of cells into lymph nodes from the blood
would be very minimal after 1 h, as this phenomenon reaches
it peak at 24 h. This difference of migratory capabilities
after in vivo labeling is demonstrated in Fig. 4. This also
Fig. 2. Recirculation of labeled blood lymphocytes into efferent
lymph. Histograms showing cell count versus CFSE ¯uorescence
intensity of efferent lymph cells collected from a prefemoral efferent
lymphatic before in vivo labeling (A), and a 2-h collection made
between 18 and 20 h after CFSE injection (B). (C) Percent of CFSE-
labeled lymphocytes found following chronic sampling of the same
prefemoral lymphatic over a 40-h period. Samples were analyzed on
different days, after daily calibration of the ¯ow cytometer.
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demonstrates that CFSE is not capable of leaving the blood
compartment in suf®cient quantity to stain lymph node cells at
the concentrations used for this study.
In vivo tracking of DC
The large increase in labeling index using this in situ method
indicated that tracking of low-frequency leukocyte populations
was possible. Afferent lymph was collected either through
direct cannulation or through the cannulation of pseudo-
afferent lymph as previously described (14). The phenotype of
labeled cells recovered in pseudo-afferent lymph 24±48 h
after in vivo labeling is shown in Fig. 5. Cells were gated to
include small lymphocytes according to previously estab-
lished forward and side-scatter parameters (15). In order to
enhance for DC inclusion, afferent lymph cells were stained
with a panel of mAb, including CD1, mannose receptor,
CD11c and CD21. It has previously been established that
antibody 20-27 (CD1) speci®cally identi®es afferent lymph DC
(16). Based on staining with CD1, cells were gated to include
all afferent lymph DC. The majority of CD1+ cells (DC),
including the labeled population, were recovered in the large-
cell (high forward scatter) gate, rather than the low forward
scatter gate used to analyze lymphocytes. When this gate was
used, labeled CD1+ cells accounted for ~0.1% of the total
population. More importantly, 54% of the larger, CFSE-labeled
cells recovered in afferent lymph are CD1+.
In addition to the simple identi®cation of labeled DC in
afferent lymph after in situ blood labeling, it was possible for
the ®rst time to assess the kinetics and recovery of labeled
afferent lymph DC. While the peak of the recovery of DC was
slightly later than lymphocytes, the magnitude of recovery was
similar for both populations (Fig. 6). These data were consist-
ent independent of whether CD1 or high expression of CD11c
was used to identify DC in afferent lymph. When the number of
labeled cells within each subset was calculated as a propor-
tion of that subset, it became clear that similar numbers of
labeled DC and labeled lymphocytes migrated into the
afferent lymph after whole-blood labeling.
Discussion
This is the ®rst report of labeling the blood in situ, even though
FITC and CFSE have been used to label cells in other tissues in
situ (17±19), and PKH-26 has been able to selectively label
neutrophils for 24 h (20). The present study is the ®rst to use
DC markers to track this minor population from blood into
normal afferent lymph.
CFSE is an ester combined with the ¯uorescein moiety. It is
highly membrane permeable, and requires esterases found in
cells to cleave the molecule and allow binding of the
Fig. 4. CFSE+ cells in spleen versus mesenteric lymph node 1 h
after in vivo labeling. Histograms showing cell count versus CFSE
¯uorescence intensity of cells from a biopsy performed on the
spleen (A) and mesenteric lymph node (B) 1 h after in vivo labeling.
Fig. 3. Reduction of labeled lymphocytes from the blood: in vitro
versus in vivo labeling. A direct comparison was made between
in vitro and in vivo labeling by plotting the reduction of labeled
lymphocytes from the blood compartment using both methods.
Results show (A) the percent of CFSE+ lymphocytes in the blood
versus time, after the cells contained within a unit of blood were
labeled in vitro with CFSE and returned to the sheep's venous
circulation (n = 5); (B) the percent of CFSE+ lymphocytes in the
blood versus time, after in vivo labeling with CFSE (n = 3). Error bars
indicate SEM.
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¯uorochrome to intracellular proteins. We found, as was
previously reported by others (21), that the intensity of
CFSE-labeled cells declines over a 24-h period, but then
stabilized, allowing long-term tracking of labeled cells. There
may be further analytical procedures which could be devel-
oped to distinguish cell division from other phenomena which
affect loss of intensity, such as cell death or turnover of labeled
intracellular elements. Labeling of platelets may allow future
studies to make relative comparisons between lymphocyte or
leukocyte subsets and these non-dividing, blood elements.
Using our labeling conditions, only blood leukocytes were
labeled. For example, insuf®cient CFSE reached lymph nodes
to directly label cells in this compartment. This is supported by
two observations made. (i) Lymph nodes collected 1 h after
blood labeling remained unlabeled. (ii) Kinetics of recovery of
labeled lymphocytes in lymph were similar to the kinetics
found with in vitro labeling studies. However, it is conceivable
that by increasing the dye concentration, blood vascular cells
and other organs/tissues might be directly labeled.
The present methodology enhances and validates a sub-
stantial literature on the use of cell-tracking dyes to de®ne
lymphocyte migration patterns (1,7,8). Leukocyte migration is
a dynamic and complex process, which requires analysis of
an ever-changing cellular mosaic in a physiological environ-
ment. In vivo cell tracking has been the principal technique to
investigate this phenomenon. While rodent studies have been
particularly useful in establishing the molecular basis of
leukocyte homing, particularly with respect to interactions
with endothelial cells (22,23), investigations in sheep have
de®ned the physiology of lymphocyte recirculation. This is a
powerful experimental approach as large animals allow
surgical techniques to sequentially sample blood and many
different lymphatic compartments during the course of a
single experiment. Chronic lymph collection in conscious
sheep, combined with ¯uorescent cell-tracking compounds
and ¯ow cytometry, has documented kinetics and quantitative
recovery of i.v. injected labeled cells. Lymphocyte migration
patterns for a variety of subsets and a variety of normal and
pathological tissues have been well characterized (4±6,10). In
fact, this physiological system has been crucial in validating
cellular tracking labels. Only viable undamaged lymphocytes
traf®c from blood to lymph (5).
Because DC have a fundamental role in antigen presenta-
tion they have received considerable attention over the last
few years (24). It should be noted that the intimate association
of veiled cells with lymphocytes was described in afferent
lymph several decades ago (25). Typically the special status
of lymphocytes has been recognized due to their recirculation
capabilities, meaning that they continuously exit the blood
compartment and return via the lymphatic system. However, a
truncated migration pathway from blood to lymph nodes via
afferent lymphatics exists for monocytes, DC and macro-
phages. It is interesting that the cellular composition of afferent
lymph in terms of the proportion of DC and macrophages to
lymphocytes is very similar to blood (~1:10). We have shown
that the capacity of DC to migrate from the blood to afferent
lymph is similar to lymphocytes. In addition, the kinetics of the
appearance of DC and lymphocytes in afferent lymph is
comparable. Since monocytes, DC and macrophages are not
found in normal efferent lymph, this indicates that selective
cellular ®ltering solely resides in the lymph node.
Surprisingly there is a lack of detailed quantitative data on
labeled leukocytes in the blood. In addition, the technical
limitations associated with various labeling techniques used
and sequential sampling have yielded a wide range of
published half-times (10,26±29). We have been able to use
the combination of this labeling technique with multiple
sequential sampling to de®ne detailed blood curves for
lymphocytes, monocytes, neutrophils and platelets (Hay and
Ristevski, in preparation). We think the application of this
method will permit a series of sound physiological experi-
ments providing new information in the areas of normal
hematology, leukemia, systemic infectious diseases and
chronic in¯ammation.
Fig. 5. Phenotype of labeled peripheral blood cells recovered in
afferent lymph. Cells collected 24±48 h after in vivo blood labeling
were reacted with appropriate antibodies and analyzed by ¯ow
cytometry. As DC are signi®cantly larger than lymphocytes, and to
allow more detailed analysis of the lymphoid and non-lymphoid
populations, cells were either gated as low side scatter/low forward
scatter (lymphocytes) or as high forward scatter/high side scatter
(DC). At least 100,000 cells were then analyzed for each antibody to
determine either the population of gated cells which were positive
for both CFSE and the antibody of interest (large number) or the
proportion of labeled cells reactive for each antibody (bracketed
number). Antibody controls not shown.
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Abbreviations
CFSE carboxy¯uorescein diacetate succinimidyl ester
DC dendritic cell
DMSO dimethyl sulfoxide
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